Trials / Unknown
UnknownNCT04929132
Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules
Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules Graded With the Breast Imaging Reporting and Data System
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS).
Detailed description
The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS). The study included patients with 4A nodules confirmed by core biopsy and/or surgery. The CEUS parameters were assessed to evaluated the added value in BI-RADS 4A nodules
Conditions
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-12-30
- Completion
- 2021-12-31
- First posted
- 2021-06-18
- Last updated
- 2021-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04929132. Inclusion in this directory is not an endorsement.